Informações:
Falhas:
ID
27854
Descrição
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01027065
Link
https://clinicaltrials.gov/show/NCT01027065
Palavras-chave
Versões (1)
- 01/12/2017 01/12/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
1 de dezembro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Chronic Hepatitis B NCT01027065
Eligibility Chronic Hepatitis B NCT01027065
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis B NCT01027065
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Hepatitis B, Chronic
Item
chronic hbv-infected patients
boolean
C0524909 (UMLS CUI [1])
Hepatitis B e antigen negative
Item
hbeag-negative patients
boolean
C0948827 (UMLS CUI [1])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Hepatitis, Chronic | Antiviral Therapy
Item
patients with active chronic hepatitis at the start of the antiviral treatment
boolean
C0019189 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
C0280274 (UMLS CUI [2])
Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable
Item
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
boolean
C0369332 (UMLS CUI [1,1])
C3827727 (UMLS CUI [1,2])
C0971023 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0384228 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
C3827727 (UMLS CUI [1,2])
C0971023 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0384228 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
entecavir | Tenofovir | Pegylated interferon alfa Acceptable
Item
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
boolean
C0971023 (UMLS CUI [1])
C0384228 (UMLS CUI [2])
C0907160 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
C0384228 (UMLS CUI [2])
C0907160 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Hepatitis C
Item
infection by hcv
boolean
C0019196 (UMLS CUI [1])
HIV-1 infection | HIV-2 infection
Item
infection by hiv-1 and /or hiv-2
boolean
C2363741 (UMLS CUI [1])
C0854094 (UMLS CUI [2])
C0854094 (UMLS CUI [2])
Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B
Item
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2,1])
C1708385 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2,1])
C1708385 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
Lamivudine | Nucleoside Analogs
Item
previous treatment by lamivudine and/or nucleosides analogues
boolean
C0209738 (UMLS CUI [1])
C1579410 (UMLS CUI [2])
C1579410 (UMLS CUI [2])
Carrier Without Activity
Item
inactive carrier
boolean
C0560175 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
C0332288 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
Liver Cirrhosis
Item
cirrhosis
boolean
C0023890 (UMLS CUI [1])
Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological
Item
other liver disease (notably from alcoholic, metabolic or immunological origin)
boolean
C0023895 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0023896 (UMLS CUI [2])
C0023895 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0311400 (UMLS CUI [3,3])
C0023895 (UMLS CUI [4,1])
C0015127 (UMLS CUI [4,2])
C0205470 (UMLS CUI [4,3])
C0205394 (UMLS CUI [1,2])
C0023896 (UMLS CUI [2])
C0023895 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0311400 (UMLS CUI [3,3])
C0023895 (UMLS CUI [4,1])
C0015127 (UMLS CUI [4,2])
C0205470 (UMLS CUI [4,3])
Autoimmune Disease
Item
history of clinical autoimmune disease or active auto-immune disease
boolean
C0004364 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type i diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Severe asthma | Pharmaceutical Preparations chronic
Item
severe asthma, presently on chronic medications
boolean
C0581126 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])